Patricia Ann Duffy

Array ( [id] => 3516678 [patent_doc_number] => 05486460 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-23 [patent_title] => 'Method and test kits for identifying Alzheimer\'s disease by testing cerebrospinal fluid' [patent_app_type] => 1 [patent_app_number] => 8/064346 [patent_app_country] => US [patent_app_date] => 1993-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1905 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/486/05486460.pdf [firstpage_image] =>[orig_patent_app_number] => 064346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4182202 [patent_doc_number] => 06093390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Methods for promoting functional regeneration of mammalian muscle by administering leukaemia inhibitor factor' [patent_app_type] => 1 [patent_app_number] => 8/062056 [patent_app_country] => US [patent_app_date] => 1993-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 40 [patent_no_of_words] => 13825 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093390.pdf [firstpage_image] =>[orig_patent_app_number] => 062056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4106238 [patent_doc_number] => 06057123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Stem cell inhibiting proteins' [patent_app_type] => 1 [patent_app_number] => 7/982759 [patent_app_country] => US [patent_app_date] => 1993-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 29 [patent_no_of_words] => 53487 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057123.pdf [firstpage_image] =>[orig_patent_app_number] => 982759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768587 [patent_doc_number] => 05756301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Endogenous taxol-like substance in human serum, monoclonal antibodies directed thereto and methods of assaying therefor' [patent_app_type] => 1 [patent_app_number] => 8/025557 [patent_app_country] => US [patent_app_date] => 1993-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9308 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756301.pdf [firstpage_image] =>[orig_patent_app_number] => 025557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3548907 [patent_doc_number] => 05547841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-20 [patent_title] => 'In vitro method for screening for drugs that inhibit production or degradation of human A4-amyloid' [patent_app_type] => 1 [patent_app_number] => 7/990893 [patent_app_country] => US [patent_app_date] => 1992-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 12528 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/547/05547841.pdf [firstpage_image] =>[orig_patent_app_number] => 990893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3569688 [patent_doc_number] => 05538845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'Beta-amyloid peptide production inhibitors and methods for their identification' [patent_app_type] => 1 [patent_app_number] => 7/831722 [patent_app_country] => US [patent_app_date] => 1992-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5899 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/538/05538845.pdf [firstpage_image] =>[orig_patent_app_number] => 831722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013295 [patent_doc_number] => 05962647 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Bovine interleukin-1.beta. protein and amino acid sequence' [patent_app_type] => 1 [patent_app_number] => 7/827250 [patent_app_country] => US [patent_app_date] => 1992-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5274 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962647.pdf [firstpage_image] =>[orig_patent_app_number] => 827250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924296 [patent_doc_number] => 05876948 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Screening methods to identify neurotoxin inhibitors' [patent_app_type] => 1 [patent_app_number] => 7/737371 [patent_app_country] => US [patent_app_date] => 1991-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 9029 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876948.pdf [firstpage_image] =>[orig_patent_app_number] => 737371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044858 [patent_doc_number] => 05869266 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Human olfactory neuron cultures to diagnose Alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 7/605788 [patent_app_country] => US [patent_app_date] => 1990-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3928 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869266.pdf [firstpage_image] =>[orig_patent_app_number] => 605788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392797 [patent_doc_number] => 06541275 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Immunoassay for F1.2 prothrombin fragment' [patent_app_type] => B1 [patent_app_number] => 07/151735 [patent_app_country] => US [patent_app_date] => 1988-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5034 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541275.pdf [firstpage_image] =>[orig_patent_app_number] => 07151735 [rel_patent_id] =>[rel_patent_doc_number] =>)